give me extransic & INTRINSIC PATHWAY OF Clothing factore with deatail and iamge

Reading File

Finding Sources

Searching Images

coagulation cascade extrinsic intrinsic pathway clotting factors diagram

Reading File

Loading Image

Reading File

I now have comprehensive information from multiple authoritative textbooks and excellent diagrams. Let me compile the full, detailed answer.

Coagulation (Clotting) Pathways: Extrinsic & Intrinsic

Blood coagulation proceeds through a cascade of sequential zymogen activations — each activated factor (serine protease) catalyzes the next — culminating in a stable fibrin clot. There are two initiating arms (extrinsic and intrinsic) that converge on a shared common pathway.

Overview Diagram

Traditional Coagulation Cascade — Intrinsic, Extrinsic & Common Pathways

Traditional coagulation cascade. TF = tissue factor; PT = phospholipids; Ca²⁺ = calcium ions; "a" suffix = activated form.

Clotting Factors Summary Table

Factor	Name	Type	Pathway
I	Fibrinogen	Substrate → Fibrin	Common
II	Prothrombin	Zymogen → Thrombin (serine protease)	Common
III	Tissue Factor (Thromboplastin)	Cofactor (membrane glycoprotein)	Extrinsic
IV	Calcium (Ca²⁺)	Cofactor	All
V	Labile factor / Proaccelerin	Cofactor	Common
VII	Proconvertin	Zymogen (Vit K-dependent)	Extrinsic
VIII	Antihemophilic factor A	Cofactor	Intrinsic
IX	Christmas factor	Zymogen (Vit K-dependent)	Intrinsic
X	Stuart-Prower factor	Zymogen (Vit K-dependent)	Common
XI	Plasma thromboplastin antecedent	Zymogen	Intrinsic
XII	Hageman factor	Zymogen	Intrinsic (contact)
XIII	Fibrin-stabilizing factor	Zymogen (transglutaminase)	Common
—	Prekallikrein (PK)	Contact factor	Intrinsic (contact)
—	HMWK (High-MW Kininogen)	Cofactor	Intrinsic (contact)
—	von Willebrand Factor (vWF)	Carrier/platelet adhesion	Supports intrinsic

Vitamin K-dependent factors (synthesized in the liver, require γ-carboxylation of Glu residues): II, VII, IX, X (and proteins C, S, Z). Warfarin blocks their synthesis.

🔴 Extrinsic Pathway ("Tissue Factor Pathway")

Trigger: Vascular injury → exposure of Tissue Factor (TF / Factor III), a subendothelial transmembrane glycoprotein abundantly expressed on fibroblasts and vascular smooth muscle cells.

Step-by-Step:

Tissue injury
     ↓
Tissue Factor (TF) exposed on subendothelium
     ↓
TF + Factor VII (circulating zymogen, Vit K-dependent)
     ↓  [Ca²⁺ required]
TF:VIIa complex (Extrinsic Tenase complex)
     ↓
Activates Factor X  →  Factor Xa      ← Enters Common Pathway
     ↓
(Also activates Factor IX  →  Factor IXa)  ← Crossover to Intrinsic

Key points:

TF acts as a cofactor for Factor VIIa, dramatically amplifying its enzymatic activity
TF:VIIa complex activates both Factor X and Factor IX — this crossover links extrinsic and intrinsic pathways
The reaction requires assembly on a phospholipid membrane surface in the presence of Ca²⁺
Factor VII's Gla residues (γ-carboxyglutamate) bind Ca²⁺ and anchor it to membrane surfaces
Assessed in the lab by Prothrombin Time (PT / INR)

🔵 Intrinsic Pathway ("Contact Activation Pathway")

Trigger: Contact of blood/plasma with a negatively charged surface (in vivo: damaged vessel collagen, platelet phospholipids; in vitro: glass).

Step-by-Step:

Contact with negatively charged surface
     ↓
Factor XII (Hageman factor)  →  Factor XIIa
     (assisted by Prekallikrein + HMWK)
     ↓
Factor XI  →  Factor XIa    [Ca²⁺]
     ↓
Factor IX  →  Factor IXa    [Ca²⁺]
     ↓
Factor IXa + Factor VIIIa + Ca²⁺ + Phospholipids
= "Intrinsic Tenase Complex" (on platelet surface)
     ↓
Factor X  →  Factor Xa      ← Enters Common Pathway

Key points:

FXII, PK, HMWK form the contact activation complex — but FXII deficiency does NOT cause clinical bleeding (it is not physiologically essential in vivo)
Factor VIII is the cofactor that, when activated to VIIIa by thrombin (feedback), dramatically accelerates IXa activity (~200,000×)
Hemophilia A = Factor VIII deficiency; Hemophilia B = Factor IX deficiency — both cause severe bleeding because this pathway is critical for amplification in vivo
Assessed in the lab by aPTT (activated Partial Thromboplastin Time)

🟣 Common Pathway

Both pathways converge here at Factor X activation.

Factor Xa + Factor Va + Ca²⁺ + Phospholipids
= Prothrombinase Complex (on platelet/cell membrane)
     ↓
Prothrombin (II)  →  Thrombin (IIa)
     ↓
Thrombin cleaves Fibrinogen (I)
     → releases Fibrinopeptide A (FPA) + Fibrinopeptide B (FPB)
     → Fibrin monomer
     ↓
Fibrin monomers spontaneously polymerize
     ↓
Thrombin activates Factor XIII  →  Factor XIIIa (transglutaminase)
     ↓
Factor XIIIa cross-links fibrin polymers covalently
     ↓
✅ STABLE CROSS-LINKED FIBRIN CLOT

Detailed Cascade with Lab Tests

Harrison's Coagulation Cascade with aPTT and PT assessment

From Harrison's Principles of Internal Medicine 22e — coagulation cascade with aPTT (intrinsic + common) and PT (extrinsic + common) correlation.

Anticoagulant Drug Targets

Coagulation cascade showing sites of anticoagulant drug action

Drug	Target	Pathway affected
Warfarin	Blocks Vit K-dependent synthesis (II, VII, IX, X)	Both
Heparin (UFH) + Antithrombin III	Inactivates IIa, Xa, IXa, XIa, XIIa	Both
LMWH (enoxaparin)	Primarily anti-Xa	Common + Intrinsic
Fondaparinux	Indirect Factor Xa inhibitor	Common
Rivaroxaban/Apixaban	Direct Factor Xa inhibitors	Common
Dabigatran	Direct thrombin (IIa) inhibitor	Common

Extrinsic vs. Intrinsic — Quick Comparison

Feature	Extrinsic	Intrinsic
Trigger	Tissue injury / TF exposure	Contact with negatively charged surface
Key initiator	Tissue Factor (III) + Factor VII	Factor XII, PK, HMWK
Speed	Fast (seconds)	Slower (minutes)
Main role in vivo	Primary initiation of clotting	Amplification of clot formation
Unique factors	VII	XII, XI, VIII (+ PK, HMWK)
Shared factor	IX (crossover from extrinsic)	—
Lab test	PT / INR	aPTT
Deficiency consequences	Factor VII deficiency → prolonged PT	Hemophilia A/B (VIII/IX deficiency) → prolonged aPTT + severe bleeding

Modern View: Cell-Based Model

The classical "two-pathway" model is now understood to be an oversimplification. The current cell-based model (Sabiston Textbook of Surgery) describes three overlapping phases:

Initiation — TF:VIIa complex (on fibroblasts/VSMC) activates small amounts of FXa and FIXa → trace thrombin
Amplification — Trace thrombin activates platelets, Factor V, Factor VIII, and Factor XI → positive feedback
Propagation — Full intrinsic tenase (IXa:VIIIa) on activated platelet surfaces generates a massive thrombin burst → stable fibrin clot

The intrinsic pathway is the main amplifier in vivo; the extrinsic pathway is the initiator. They are strongly interconnected: IXa and Xa from the intrinsic pathway can activate Factor VII of the extrinsic pathway, and conversely TF:VIIa activates Factor IX.

Sources:

Harper's Illustrated Biochemistry, 32nd Ed., Figures 55-2 & 55-3
Medical Physiology (Boron & Boulpaep), Table 18-4 & pp. 643–645
Sabiston Textbook of Surgery, Chapter 100 (Hemostasis)
Harrison's Principles of Internal Medicine, 22e, Figure 116-1

This is a shared conversation. Sign in to Orris to start your own chat.